Use of a Pharmacophore Model To Discover a New Class of Influenza Endonuclease Inhibitors
- 20 February 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (7) , 1153-1164
Abstract
Data from both our own and literature studies of the biochemistry and inhibition of influenza virus endonuclease was combined with data on the mechanism of action and the likely active site mechanism to propose a pharmacophore. The pharmacophore was used to design a novel structural class of inhibitors, some of which were found to have activities similar to that of known influenza endonuclease inhibitors and were also antiviral in cell culture.Keywords
This publication has 21 references indexed in Scilit:
- PvuII endonuclease contains two calcium ions in active sites11Edited by A. R. FershtJournal of Molecular Biology, 2000
- The active site of Serratia endonuclease contains a conserved magnesium-water clusterJournal of Molecular Biology, 1999
- Metal Ion Catalysis of RNA Cleavage by the Influenza Virus EndonucleaseBiochemistry, 1999
- Ribonuclease AChemical Reviews, 1998
- Hydrolysis of a slow cyclic thiophosphate substrate of RNase T1 analyzed by time-resolved crystallographNature Structural & Molecular Biology, 1998
- Taking aim at a moving target-inhibitors of influenza virus Part 1 : virus adsorption, entry and uncoatingDrug Discovery Today, 1996
- Studies on New Acidic Azoles as Glucose-Lowering Agents in Obese, Diabetic db/db MiceJournal of Medicinal Chemistry, 1995
- X-ray structure of the DNase I-d(GGTATACC)2 complex at 2·3Å resolutionJournal of Molecular Biology, 1992
- Synthesis of 1-HydroxyoxindolesSynthetic Communications, 1990
- N-hydroxy-imides. Part II. Derivatives of homophthalic and phthalic acidsJournal of the Chemical Society (Resumed), 1955